Drug companies benefit from FDA regulation because compliance costs are a fixed cost startups cannot bear, excluding rivals; in Bruce Yandle's bootleggers-and-Baptists terms, companies are the bootleggers and safety advocates are the Baptists, producing a strong political coalition for an overly zealous FDA.
causalpending
Speaker
Russ RobertsEvidence Quote
“The cynical argument is that the drug companies benefit from FDA regulation”
Created: 10/30/2026, 3:22:16 PM
Your notes
Loading notes...